We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+31.52%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$874M
AUM Growth
-$25.1M
Cap. Flow
-$193M
Cap. Flow %
-22.04%
Top 10 Hldgs %
51.18%
Holding
205
New
56
Increased
8
Reduced
44
Closed
39

Top Buys

Rank Stock Value
1
ANGI icon
Angi Inc
ANGI
+$19.4M
2
PPLI
People Inc
PPLI
+$18.5M
3
W icon
Wayfair
W
+$16.8M
4
CPS icon
Cooper-Standard Automotive
CPS
+$11.3M
5
CDLX icon
Cardlytics
CDLX
+$9.78M

Top Sells

Rank Stock Value
1
CVNA icon
Carvana
CVNA
+$37.7M
2
NIHD
NII Holdings, Inc. Common Stock
NIHD
+$25.8M
3
RDHL
Redhill Biopharma
RDHL
+$15.6M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$12.9M
5
ENVA icon
Enova International
ENVA
+$11M

Sector Composition

Rank Sector Weight
1 Healthcare 23.11%
2 Consumer Discretionary 22.28%
3 Communication Services 10.57%
4 Financials 4.06%
5 Materials 2.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NESRW
76
DELISTED
National Energy Services Reunited Corp. Warrant
NESRW
$653K 0.07%
725,000
– –
GEF.B icon
77
Greif Class B
GEF.B
$4.11B
$617K 0.07%
11,910
– –
APTO
78
DELISTED
Aptose Biosciences, Inc.
APTO
$567K 0.06%
+222
New +$289K
IMVTW
79
DELISTED
Immunovant, Inc. Warrants expiring 12/18/2024
IMVTW
$557K 0.06%
+278,258
New +$563K
SONG
80
DELISTED
Akazoo SA
SONG
$527K 0.06%
100,000
– –
TIBRW
81
DELISTED
Tiberius Acquisition Corporation Warrant
TIBRW
$513K 0.06%
+450,000
New +$513K
ORSNU
82
DELISTED
Orisun Acquisition Corp. Unit
ORSNU
$508K 0.06%
50,000
– –
ATRA icon
83
Atara Biotherapeutics
ATRA
$75.5M
$412K 0.05%
+1,000
New +$345K
DSX icon
84
Diana Shipping
DSX
$302M
$350K 0.04%
160,784
-229,154
-59% -$555K
PVLA
85
Palvella Therapeutics
PVLA
$1.99B
$326K 0.04%
1,125
-753
-40% -$209K
TCON
86
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$316K 0.04%
6,750
-6,238
-48% -$410K
VTIQW
87
DELISTED
VectoIQ Acquisition Corp. Warrant
VTIQW
$295K 0.03%
500,000
– –
ISEE
88
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$288K 0.03%
+33,608
New +$120K
LGC.WS
89
DELISTED
Legacy Acquisition Corp. Warrants, exercisable for one-half of one share of Class A Common Stock for
LGC.WS
$269K 0.03%
500,000
– –
SONGW
90
DELISTED
Akazoo SA Warrant
SONGW
$245K 0.03%
489,700
-10,300
-2% -$6.27K
PRVB
91
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$233K 0.03%
+15,608
New +$139K
IBRX icon
92
ImmunityBio
IBRX
$7.51B
$223K 0.03%
+58,748
New +$100K
SSI
93
DELISTED
Stage Stores Inc
SSI
$220K 0.03%
+27,056
New +$105K
VERU icon
94
Veru
VERU
$36M
$219K 0.03%
+6,540
New +$146K
ABUS icon
95
Arbutus Biopharma
ABUS
$857M
$215K 0.02%
+77,368
New +$125K
IMVT icon
96
Immunovant
IMVT
$7.93B
$213K 0.02%
13,400
-786,600
-98% -$8.81M
BYND icon
97
CALL
Beyond Meat
BYND
$292M
$212K 0.02%
2,800
-149,700
-98% -$13.9M
HROW icon
98
Harrow
HROW
$1.45B
$211K 0.02%
+27,136
New +$157K
LSEAW
99
DELISTED
Landsea Homes Corporation Warrant
LSEAW
$209K 0.02%
450,000
– –
ARAV
100
DELISTED
Aravive, Inc. Common Stock
ARAV
$202K 0.02%
+14,756
New +$130K
2 3
4
5 6

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, 683 Capital Management held 205 positions worth $874M, down 2.8% from $899M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

683 Capital Management withdrew a net $193M in Q4 2019, closing 39 positions and reducing 44 holdings. Its most notable exit was NII Holdings, Inc. Common Stock, an estimated $25.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, 683 Capital Management opened a new position in Angi Inc worth $22M.

  • 683 Capital Management's largest Q4 2019 buy was Angi Inc: 260,000 shares worth $22M.
  • 683 Capital Management added most to Cardlytics in Q4 2019, an estimated $9.78M increase.
  • 683 Capital Management's biggest Q4 2019 reduction was Carvana, cutting an estimated $37.7M.
  • 683 Capital Management fully exited NII Holdings, Inc. Common Stock in Q4 2019, selling an estimated $25.8M.
  • 683 Capital Management's ten largest holdings make up 51% of its $874M portfolio in Q4 2019.
  • 683 Capital Management opened 56 new positions and closed 39 in Q4 2019.
  • 683 Capital Management's portfolio value fell 2.8% quarter-over-quarter to $874M.

Based on 683 Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.